Navigation Links
CPhI Conferences Introduces New Lunchtime Education Series
Date:9/21/2011

AMSTERDAM, Sept. 21, 2011 /PRNewswire/ -- Leading events organiser UBM Conferences, a division of UBM Plc (LSE: UBM), today announced details of the newly introduced CPhI Lunchtime Education Series to be hosted 25th to 27th October 2011 at its annual flagship CPhI Worldwide event which is focused on pharmaceutical ingredients. Organised by CPhI Conferences, the Series will run in a workshop format with six interactive sessions over the three days of co-located exhibitions CPhI Worldwide for pharmaceutical ingredients, ICSE for contract and outsourced services and logistics, P-MEC for pharmaceutical technology and machinery and the new InnoPack show for pharmaceutical packaging needs.

"The Lunchtime Education Series has been introduced to provide attendees with the opportunity to analyse and discuss some of the key issues and trends currently affecting the pharma market in a format that comfortably fits into their busy schedules while onsite at the events," commented Michael Payne, Conference Programme Editor for the CPhI Worldwide Pre-Show Conference Series. "In addition to the educational value of the sessions, the registration fee for the Series will also include unique networking opportunities during the lunch breaks."

Each day will provide two half-hour workshops, separated by a half hour break for hosted lunch. The programme will run as follows: Workshop One: Increasing Sales by 30% - The One Tool that Rewards Change, Pharmaceutical GMP in Emerging Regions (Perspectives from China and India); Workshop Two: Innovation and Development in Drug Delivery, Opportunities and Challenges of Pharma Mergers and Acquisitions; and Workshop Three: Trends in Consumer Health through Innovations, Developing a Comprehensive Pricing and Reimbursement Structure. Each Workshop will be presented by an industry-leading expert that will provide specialist insight on key strategic and operational issues affecting drug development, delivery and commercialisation.

For more information, or to register for the CPhI Lunchtime Conference Series, please visit: www.cphi.com/lunchtime-seminars

UBM Live's market leading annual schedule of pharma brands includes the upcoming CPhI Worldwide (25-27, October, Messe Frankfurt, Germany 2011), India (30 November-2 December, Bombay Exhibition Centre, Mumbai, India, 2011), CPhI Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Centre, Japan), CPhI China (26-28 June, 2012, SNIEC, Shanghai, China), and CPhI South America (21-23 August, 2012, Transamerica Expo Centre, Brazil).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Conferences
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences
2. Pharmasset to Present at Two Upcoming Conferences
3. Avanir Pharmaceuticals to Participate in Two Investor Conferences
4. AcelRx Pharmaceuticals to Present at Two Healthcare Investor Conferences in the Second Half of September
5. PDL BioPharma to Present at Upcoming Investor Conferences
6. NeoStem Announces Participation in Multiple September Conferences
7. ResMed Inc. to Present at Upcoming Conferences
8. West to Present at Upcoming Investor Conferences
9. Codexis to Present at Three Investor Conferences in September
10. MAP Pharmaceuticals to Present at Upcoming Investor Conferences
11. Unilife to Participate in Two Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):